Calcium intervention ameliorates experimental model of multiple sclerosis

Oman Medical Journal

Volumn 29, Issue 3, 2014, Pages 185-189

  Haghmorad, Dariush ^a   Mahmoudi, Mohammad B ^b   Mahmoudi, Mahmoud ^a   Rab, Shahrzad Z T ^a   Rastin, Maryam ^a   Shegarfi, Hamid ^c   Azizi, Gholamreza ^d   Mirshafiey, Abbas ^e  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF OSLO   (Norway)

^d ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium; CNS; EAE; MS; Nitric oxide

Indexed keywords

CALCIUM; GAMMA INTERFERON; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ASSAY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY SCORE; DRUG EFFICACY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GRIESS REACTION; HISTOPATHOLOGY; IMMUNIZATION; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PROCEDURES; SCORING SYSTEM; SPLEEN CELL;

EID: 84901617551     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2014.46     Document Type: Article

References (36)

1. Vanheel A, Daniels R, Plaisance S, Baeten K, Hendriks JJ, Leprince P, et al. Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. PLoS One 2012;7(4):e35544.
2. Guglielmetti C, Praet J, Rangarajan JR, Vreys R, De Vocht N, Maes F, et al. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum. Neuroimage 2013 Feb 1;86:99-110.
3. Zaheer S, Wu Y, Bassett J, Yang B, Zaheer A. Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis. Neurochem Res 2007 Dec;32(12):2123-2131.
4. Farnoush R, Sahebolzamani M, Aliloo L, Rahmani A. Educational, Psycho Mental and Socio economical needs of an Iranian Cohort with Multiple Sclerosis. Oman Med J 2010 Jan;25(1):22-25.
5. Roy M, Richard JF, Dumas A, Vallières L. CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis. J Neuroinflammation 2012;9:18.
6. Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, Miller SD. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 2008 May;180(10):6457-6461.
7. Selvaraj RK, Geiger TL. Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance. J Immunol 2008 Mar;180(5):2830-2838.
8. Horstmann L, Schmid H, Heinen AP, Kurschus FC, Dick HB, Joachim SC. Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model. J Neuroinflammation 2013;10(1):120.
9. Furlan R, Kurne A, Bergami A, Brambilla E, Maucci R, Gasparini L, et al. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis. J Neuroimmunol 2004 May;150(1-2):10-19.
10. Li X, Li TT, Zhang XH, Hou LF, Yang XQ, Zhu FH, et al. Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell. PLoS One 2013;8(8):e74108.
11. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000 Aug;177(2):95-103.
12. Moriya M, Nakatsuji Y, Miyamoto K, Okuno T, Kinoshita M, Kumanogoh A, et al. Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis. Neurosci Lett 2008 Aug;440(3):323-326.
13. Kumar A, Khan S; Lakshman K; Jayaveera KN; Sheshadri Shekar D; Narayan Swamy VB; Velumurga C. In Vitro α-Amylase Inhibition and Antioxidant Activities of Methanolic Extract of Amaranthus Caudatus Linn. Oman Med J 2011 May;26(3):166-170.
14. Baird GS, Rainey PM, Wener M, Chandler W. Reducing routine ionized calcium measurement. Clin Chem 2009 Mar;55(3):533-540.
15. Radermacher AN, Crabtree GR. Monster protein controls calcium entry and fights infection. Immunity 2008 Jan;28(1):13-14.
16. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003 Jan;134(1-2):128-132.
17. Andjelkovic Z, Vojinovic J, Pejnovic N, Popovic M, Dujic A, Mitrovic D, et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999 Jul-Aug;17(4):453-456.
18. Wang Y, Marling SJ, Zhu JG, Severson KS, DeLuca HF. Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor. Proc Natl Acad Sci U S A 2012 May;109(22):8501-8504.
19. Peiris M, Monteith GR, Roberts-Thomson SJ, Cabot PJ. A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies. J Neurosci Methods 2007 Jul;163(2):245-254.
20. Jiang HR, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, Goodyear CS, et al. Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol 2009 Jan;182(2):1167-1173.
21. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986 Oct;21(2):193-200.
22. Bak M, Serdaroglu E, Guclu R. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol 2006 Mar;21(3):350-354.
23. Merki-Feld GS, Neff M, Keller PJ. A 2-year prospective study on the effects of depot medroxyprogesterone acetate on bone mass-response to estrogen and calcium therapy in individual users. Contraception 2003 Feb;67(2):79-86.
24. Skundric DS, Zakarian V, Dai R, Lisak RP, Tse HY, James J. Distinct immune regulation of the response to H-2b restricted epitope of MOG causes relapsingremitting EAE in H-2b/s mice. J Neuroimmunol 2003 Mar;136(1-2):34-45.
25. Natarajan C, Muthian G, Barak Y, Evans RM, Bright JJ. Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis. J Immunol 2003 Dec;171(11):5743-5750.
26. Nencini C, Cavallo F, Capasso A, Franchi GG, Giorgio G, Micheli L. Evaluation of antioxidative properties of Allium species growing wild in Italy. Phytother Res 2007 Sep;21(9):874-878.
27. Phizackerley PJ, Al-Dabbagh SA. The estimation of nitrate and nitrite in saliva and urine. Anal Biochem 1983 May;131(1):242-245.
28. Kayhan B, Aharoni R, Arnon R. Glatiramer acetate (Copaxone) regulates nitric oxide and related cytokine secretion in experimental autoimmune encephalomyelitis. Immunol Lett 2003 Sep;88(3):185-192.
29. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 1989 Mar;142(5):1523-1527.
30. Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 1995 Jul;25(7):1951-1959.
31. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988 Oct;78(4):318-323.
32. Miller A, al-Sabbagh A, Santos LM, Das MP, Weiner HL. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 1993 Dec;151(12):7307-7315.
33. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (New York, NY. 1994 Aug 26;265(5176):1237-40.
34. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994 Nov;180(5):1961-1966.
35. Xiao BG, Ma CG, Xu LY, Link H, Lu CZ. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Mol Immunol 2008 Feb;45(4):1191-1196.
36. Kizelsztein P, Ovadia H, Garbuzenko O, Sigal A, Barenholz Y. Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis. J Neuroimmunol 2009 Aug;213(1-2):20-25.